{
    "clinical_study": {
        "@rank": "30120", 
        "arm_group": [
            {
                "arm_group_label": "Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy"
            }, 
            {
                "arm_group_label": "Pancreaticoduodenectomy"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is being done to learn more about how different surgery procedures bring back the\n      quality of life.After removing the small intestine at least 20cm in patients with pancreatic\n      cancer, Some patients develop problems because they are disorder their digestive system,\n      such as cramping, heartburn,vomiting."
        }, 
        "brief_title": "A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pancreatic Cancer", 
        "condition_browse": {
            "mesh_term": "Pancreatic Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient 30 years of age or older\n\n          -  Pathologically confirmed pancreatic cancer (biopsy may be performed at our\n             institution)\n\n          -  No evidence of metastases(a)\n\n          -  decide performe Roux-en-Y(b)\n\n          -  single Roux-en-Y reconstruction is technically feasible(c)\n\n          -  Patients will be registered and consent obtained, if the surgeon believes there is no\n             evidence of metastases. If metastatic disease is identified at the time of operation,\n             the patient will not be randomized.\n\n          -  Patients will be conditionally enrolled, and consent obtained, if the surgeon\n             believes the patient may need a sngle Roux-en-Y at the time of operation. If a sngle\n             Roux-en-Y is not performed, the patient will not be randomized.\n\n          -  the surgeon feels that the single Roux-en-Y is not technically feasible at the time\n             of operation,the patients will be excluded. This may be due to prior abdominal\n             surgery, anatomic variants, or anything else at the surgeon's discretion.\n\n        Exclusion Criteria:\n\n          -  Not expected to be able to provide follow-up over 2 years (due to geographic or other\n             limitations)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with pancreatic cancer"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926717", 
            "org_study_id": "GYGDWK-02"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy", 
        "lastchanged_date": "August 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Guiyang", 
                    "country": "China", 
                    "state": "Guizhou", 
                    "zip": "550004"
                }, 
                "name": "The Affiliated Hospital of Guiyang Medical College"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "other_outcome": {
            "measure": "The relief of abdominal pain symptom", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for overall 3 year after surgery"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The secretion function of the pancreas", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for overall 3 year after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926717"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The First Affiliated Hospital of Guangzhou Medical University", 
            "investigator_full_name": "Chengyi Sun", 
            "investigator_title": "Department of Hepatobiliary Surgery", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The function of biliary tract", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for overall 3 year after surgery"
        }, 
        "source": "The First Affiliated Hospital of Guangzhou Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chengyi Sun", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2010"
    }
}